Cita APA

Mehrad, M., Roy, S., LaFramboise, W. A., Petrosko, P., Miller, C., Incharoen, P., & Dacic, S. (2018). KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma. Histopathology.

Chicago Style Citation

Mehrad, Mitra, Somak Roy, William A. LaFramboise, Patti Petrosko, Caitlyn Miller, Pimpin Incharoen, i Sanja Dacic. "KRAS Mutation Is Predictive of Outcome in Patients With Pulmonary Sarcomatoid Carcinoma." Histopathology 2018.

Cita MLA

Mehrad, Mitra, et al. "KRAS Mutation Is Predictive of Outcome in Patients With Pulmonary Sarcomatoid Carcinoma." Histopathology 2018.